Literature DB >> 6129410

Brain histidine decarboxylase activity in Parkinson's disease.

M Garbarg, F Javoy-Agid, J C Schwartz, Y Agid.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6129410     DOI： 10.1016/s0140-6736(83)91613-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  The histamine H3 receptor: from discovery to clinical trials with pitolisant.

Authors:  Jean-Charles Schwartz
Journal:  Br J Pharmacol       Date:  2011-06       Impact factor: 8.739

Review 2.  Interactions of the histamine and hypocretin systems in CNS disorders.

Authors:  Ling Shan; Yves Dauvilliers; Jerome M Siegel
Journal:  Nat Rev Neurol       Date:  2015-06-23       Impact factor: 42.937

Review 3.  Thr105Ile (rs11558538) polymorphism in the histamine N-methyltransferase (HNMT) gene and risk for Parkinson disease: A PRISMA-compliant systematic review and meta-analysis.

Authors:  Félix Javier Jiménez-Jiménez; Hortensia Alonso-Navarro; Elena García-Martín; José A G Agúndez
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

Review 4.  Histamine and the striatum.

Authors:  J Paul Bolam; Tommas J Ellender
Journal:  Neuropharmacology       Date:  2015-08-11       Impact factor: 5.250

Review 5.  Changes in Histaminergic System in Neuropsychiatric Disorders and the Potential Treatment Consequences.

Authors:  Ling Shan; Dick F Swaab
Journal:  Curr Neuropharmacol       Date:  2022       Impact factor: 7.708
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.